Pharmaceuticals
Aurobindo Pharma selected for IDMA''s patents appreciation award.
By Our Corporate Bureau | 15 Dec 2005
Final US FDA approval for Aurobindo''s Mirtazapine oral disintegrating tablets
By Our Corporate Bureau | 14 Dec 2005
Aurobindo Pharma''s anti-AIDS drug selected by WHO
By Our Corporate Bureau | 12 Dec 2005
Natco Pharma receives Patent Appreciation Award
By Our Corporate Bureau | 12 Dec 2005
Transgene Biotek develops oral vaccines for diabetes and Hepatitis B
By Our Corporate Bureau | 07 Dec 2005
Ranbaxy offers to help U S combat avian flu
By | 02 Dec 2005
Lupin receives US FDA approval for Cephalexin capsules
By Our Corporate Bureau | 01 Dec 2005
New Indo-UK JV company to recruit patients for drug trials
By Our Corporate Bureau | 01 Dec 2005
Tentative US FDA approval for Zydus Cadila's gatifloxacin tablets
By Our Corporate Bureau | 29 Nov 2005
Lupin receives IND approval from DCGI for Desoris LLL-3348
By Our Corporate Bureau | 28 Nov 2005
Government to set up separate pricing models for different drug categories
By Our Corporate Bureau | 28 Nov 2005
Ranbaxy honours scientists for outstanding research
By The foundation has bee | 28 Nov 2005
Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement
By Mumbai: | 24 Nov 2005
US Court of Appeals upholds preliminary injunction against Ranbaxy
By Ranbaxy had appealed t | 23 Nov 2005
AstraZeneca sues Ranbaxy on Nexium patent
By Our Corporate Bureau | 22 Nov 2005
Zydus Cadila receives approval for Sertraline from AFSSAPS, France
By Our Corporate Bureau | 22 Nov 2005
Dr Reddy''s to acquire Roche business in Mexico
By Our Corporate Bureau | 08 Nov 2005
Venkat Pharma secures $400,000-US order for dietary supplements
By Our Corporate Bureau | 02 Nov 2005
AstraZeneca and Nicholas Piramal sign ''development and know-how'' agreement
By Mumbai: | 27 Oct 2005
CRISIL reaffirms Ranbaxy''s outstanding ratings despite court ruling
By | 15 Oct 2005
Glenmark Pharmaceuticals targets GPs
By Our Corporate Bureau | 10 Oct 2005
Orchid, AstraZenwca, receive Frost and Sullivan pharma awards
By Our Corporate Bureau | 03 Oct 2005
Zydus Cadila receives tentative US FDA approval for Ribavirin tablets
By Our Corporate Bureau | 03 Oct 2005
Aurobindo receives approval for sertraline hydrochloride tablets
By Our Corporate Bureau | 27 Sep 2005
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
